Agents and Actions

, Volume 9, Issue 4, pp 350–357 | Cite as

Vitamin E-induced chronic inflammation in rats

  • Joseph W. Berkenkopf
  • Barry N. Lutsky
Immunosuppression and Inflammation

Abstract

Sub-plantar injection of vitamin E (VE) oil produces a highly localized, chronic inflammation which is sustained for at least 8 weeks. As a result of studies using mediator inhibitors and depletors, it appears that histamine, serotonin, kinins, and prostaglandins may be involved in at least the early response to VE. This early phase is dominated by a massive influx of neutrophils, with the reaction rapidly progressing to a sustained mononuclear cell pathology. Results of studies in leucopenic rats suggest that edema formation and accumulation of white cells may be dissociable, although at this time it is not possible to conclude that edema can occur in the absence of cells since profoundly leucopenic rats are still able to locally mobilize polymorphonuclear cells in response to VE. Vitamin E-induced inflammation, produced under the conditions described, can be effectively suppressed by corticosteroids but seems relatively insensitive to the action of most non-steroidal anti-inflammatory agents tested.

Keywords

Corticosteroid Serotonin Histamine Prostaglandin Mononuclear Cell 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    E.M. Glenn, W.L. Miller andC.A. Schlagel,Metabolic Effects of Adrenocortical Steroids in Vivo and in Vitro: Relationship to Antiinflammatory Effects, Recent Progr. Hormone Res.XIX, 107–199 (1963).Google Scholar
  2. [2]
    E.M. Glenn,Steroids, Nonsteroids, Intermediary Metabolism, Inflammation and Their Probable Interrelationships, in:Hormonal Steroids, Biochemistry, Pharmacology, and Therapeutics, Proceedings of the First International Congress on Hormonal Steroids1, 319–349 (1964).Google Scholar
  3. [3]
    E.M. Glenn, J. Gray andW. Kooyers,Chemical Changes in Adjuvant-Induced Polyarthritis of Rats, Amer. J. vet. Res.26, 1195–1203 (1965).PubMedGoogle Scholar
  4. [4]
    E.M. Glenn, B.J. Bowman andT.C. Koslowske,The Systemic Response to Inflammation, Biochem. Pharmacol., Suppl., 27–49. Pergamon Press, Oxford, England.Google Scholar
  5. [5]
    J. van der Vies, R.F.M. Bakker andD. de Wied,Correlated Studies on Plasma Corticosterone and on Adrenal Steroid Formation Rate in Vitro, Acta Endocr.34, 513–523 (1960).Google Scholar
  6. [6]
    D.J. Finney,Statistical Method in Biological Assay, Second Edition (Hafner Publishing Company, New York, 1964).Google Scholar
  7. [7]
    L. Katz andS.J. Piliero,A Study of Adjuvant-Induced Polyarthritis in the Rat with Special Reference to Associated Immunological Phenomena, Ann. N.Y. Acad. Sci.147, 515 (1969).Google Scholar
  8. [8]
    A.M. Dvorak andH.F. Dvorak,Structure of Freund's Complete and Incomplete Adjuvants: Relation of Adjuventicity to Structure, Immunology27, 99–113 (1974).PubMedGoogle Scholar
  9. [9]
    Practical Immunology (Eds. L. Hudson and F. Hay; Blackwell Science Publications, Oxford, London, 1976), p. 9.Google Scholar
  10. [10]
    M.W. Whitehouse, K.J. Orr, F.W.J. Beck andC.M. Pearson,Freund's Adjuvants: Relationship of Arthritogencity and Adjuventicity in Rats to Vehicle Composition, Immunology27, 311–330 (1974).PubMedGoogle Scholar
  11. [11]
    R.N. Traub, A.R. Krantz andD.W. Dresser,The Effect of Localized Injection of Adjuvant Material on the Draining Lymph Node. I. Histology, Immunology18, 171–186 (1970).PubMedGoogle Scholar
  12. [12]
    D.W. Dresser,Adjuventicity of Vitamin A, Nature217, 527–529 (1968).PubMedGoogle Scholar
  13. [13]
    J.K. Spitznagel andA.C. Allison,Mode of Action of Adjuvants: Retinol and Other Lysosome-Labilizing Agents as Adjuvants, J. Immunol.104, 119–127 (1970).PubMedGoogle Scholar
  14. [14]
    C. de Duve, R. Wittiaux andM. Wibo,Effects of Fat-Soluble Compounds on Lysosomes in Vitro, Biochem. Pharmacol.9, 97–116 (1962).CrossRefPubMedGoogle Scholar
  15. [15]
    M. Di Rossa andL. Sorrentino,Some Pharmacodynamic Properties of Carrageenan in the Rat, Brit. J. Pharmacol.38, 214–220 (1970).Google Scholar
  16. [16]
    P. Crunkhorn andS.C.R. Meacock,Mediators of the Inflammation Induced in the Rat Paw by Carrageenan, Brit. J. Pharmacol.42, 392–402 (1971).Google Scholar
  17. [17]
    M. Di Rosa, J.P. Giroud andD.A. Willoughby,Studies of the Mediators of the Acute Inflammatory Response Induced in Rats in Different Sites by Carrageenan and Turpentine, J. Path.104, 15–29 (1971).CrossRefPubMedGoogle Scholar
  18. [18]
    T.N. Bhalla andK.K. Tangri,The Time Course of the Carrageenan-Induced Oedema of the Paw of the Rat, J. Pharm. Pharmacol.22, 721 (1970).PubMedGoogle Scholar
  19. [19]
    M.E. Webster, H.M. Maling, M.H. Zweig, M.A. Williams andW. Anderson, Jr.,Urate Crystal Induced Inflammation in the Rat: Evidence for the Combined Actions of Kinins, Histamine and Components of Complement, Immunological Communications1, 185–198 (1972).PubMedGoogle Scholar
  20. [20]
    T. Astrup, I.B. Galsmar andM. Volkert,Polysaccharide Sulfuric Acids as Anticoagulants, Acta physiol. scand.8, 215–226 (1944).Google Scholar
  21. [21]
    V. Eisen andC. Loveday,In Vivo Effects of Cellulose Sulfate on Plasma Kininogen, Complement and Inflammation, Brit. J. Pharmacol.42, 383–391 (1971).Google Scholar
  22. [22]
    M. Di Rosa andD.A. Willoughby,Screens for Antiinflammatory Drugs, J. Pharm. Pharmacol.23, 297–298 (1971).PubMedGoogle Scholar
  23. [23]
    R. Vinegar, J.F. Truax andJ.L. Selph,Quantitative Studies of the Pathway to Acute Carrageenen Inflammation, Pathways to Inflammation, Fed. Proc.35, 2447–2456 (1976).PubMedGoogle Scholar
  24. [24]
    S.C.R. Meacock andE.A. Kitchen,Some Effects of Non-Steroidal Anti-Inflammatory Drugs on Leucocyte Migration, Agents and Actions6, 320–325 (1976).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1979

Authors and Affiliations

  • Joseph W. Berkenkopf
    • 1
  • Barry N. Lutsky
    • 1
  1. 1.Department of PhysiologySchering CorporationBloomfieldUSA

Personalised recommendations